Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

Clinical trial NCT06673043 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06673043
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Lupus Erythematosus, Systemic

Start date: 2025-02-28
Primary completion: 2028-06-30
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.